Cadent Therapeutics

Cadent Therapeutics is a precision neuroscience company developing novel drugs to modulate and regulate brain rhythms, restoring cognitive and motor function in patients with severe neurological disorders. The company leverages its unique precision neuroscience approach, combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules for treating movement and cognitive disorders. Currently in early clinical development, Cadent is rapidly advancing its therapies for the treatment of spinocerebellar ataxia, essential tremor, and schizophrenia.